Update shared on 08 Nov 2025
Pandox's analyst price target remains unchanged at 220. Analysts anticipate that improved revenue growth will outweigh the impact of a slightly higher discount rate and lower profit margin expectations.
What's in the News
- Pandox AB is actively seeking new acquisitions and value-creative investments. Leadership has highlighted the favorable market environment for both asset disposals and acquisitions. (Key Developments)
- The company completed the acquisition of Elite Hotel Frost Kiruna. The hotel property will be financially included from 30 September 2025 and reported in the Leases segment. The transaction value is approximately SEK 347 million. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target remains steady at SEK 220.
- Discount Rate has risen slightly, from 9.66% to 9.69%.
- Revenue Growth expectations have shifted from a 9.27% contraction to a positive 4.24% outlook.
- Net Profit Margin projections have fallen significantly, decreasing from 50.04% to 33.50%.
- Future P/E has decreased marginally, moving from 20.77x to 20.36x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.